Latest Zofran Child Birth Defect Lawsuits
03 July 2015

Birth Defect Stats And Zofran Court Cases In Maine

Almost 70-80% of pregnant women experience some sort of morning sickness. In severe cases of morning sickness, some women have what is known as hypermesis gravidarum (HG), which is severe nausea possibly caused by a rise in hormones.HG symptoms are most prevalent in the first 12 weeks of pregnancy. Women who suffer from HG in their pregnancies can remedy this by taking anti-nausea medications. One of those medications that pregnant women have been prescribed is called Ondansetron, also known as Zofran.

Ondansetron is a drug that was originally given permission for distribution and use by the Food and Drug Administration (FDA) in 1991. The FDA granted permission of the drug’s use for nausea relief in cancer patients going through chemotherapy and in patients who have undergone a surgical procedure. However, makers of the drug, GlaxoSmithKline (GSK), further marketed Zofran as an “off-label” drug leading to it being prescribed by OB/GYNs to pregnant women suffering from HG or severe morning sickness and vomiting. The FDA never approved Zofran as a drug for morning sickness. Because of the misrepresentation of the use of the drug for expectant mothers, lawsuits have now been brought forward against the makers of the drug with claims that Zofran caused a baby to be born with abnormalities.

Maine: Birth Defect Stats

There have been several studies conducted regarding birth abnormalities when Zofran was used by an expectant mom. One of those studies came from BioMed International in 2013, conducted by Australian doctors researching the afore  mentioned off-label use of Zofran. 96,968 births from 2002 to 2005 were reviewed, where 251 pregnant women were administered Zofran. Of those women who took Zofran in the early stages of their pregnancy, it was revealed that there was 20% increased risk of a baby being born with a severe defect if Zofran was present in utero in the first trimester. For more studies information go here.

According to the CDC one in 33 births in the United States ends up as a birth abnormality of sorts. Birth abnormalities are not rare and how they come about ranges from genetic disorders, medical malpractice and even drugs that were taken during pregnancy.

The number of Maine inhabitants as of the last census data stands at 1,330,089. Using this figure it is believed that 723 births in Maine ended up with a birth abnormality. In order to deduce the number of possible Zofran claims in Maine, our attorneys have evaluated the state by using the clinical studies ratios that convey particular types of defects that result from Zofran usage, the population, and birth data in Maine.

Maine’s five biggest cities population data is:

  • Portland- 66,194 population
  • Lewiston- 36,592 population
  • Bangor- 33,039 population
  • West Scarborough- 27,706 population
  • South Portland- 25,002 population

Likely Cleft Palate Abnormalities & CHD Figures In Maine & Its Biggest Cities

Going by the recorded Maine population of 1,330,089 we have evaluated a possible 123 births that are a type of cleft palate / cleft lip and as many as 600 atrial septal defect (ASD) or ventricular septal defects (VSD) (also known as congenital heart defects CHDs), that occurred because of Zofran usage in the early stages of pregnancy. For Maine’s five biggest cities the birth abnormalities are evaluated below:

  • Portland- 81 birth abnormalities with almost 6 cleft palate, and 75 CHDs
  • Lewiston- 67 birth abnormalities with almost 3 cleft palate, and 64 CHDs
  • Bangor- 65 birth abnormalities with almost 3 cleft palate, and 62 CHDs
  • West Scarborough- 63 birth abnormalities with almost 3 cleft palate, and 60 CHDs
  • South Portland- 62 birth abnormalities with almost 3 cleft palate, and 59 CHDs

Negative Effects Associated With Zofran

As already mentioned, Zofran has been conveyed as the agent behind children being born with major birth deformities in recently filed court cases. In all cases the mother took Zofran in order to remedy HG or NVM experienced during pregnancy.The charges base these accusations on the various studies performed all over the world about the negative effects Zofran has on an unborn baby.

Although GSK, refuses to acknowledge the negative effects their drug causes and has caused to many babies, the following are the thus far, some of the documented negative effects of Zofran when taken in the early stages of pregnancy:

  • Septal Defects
  • Kidney Malformations
  • Cleft Palate
  • Facial Dysmorphia
  • Syndactyly
  • Low set ears
  • Bicuspid aortic stenosis
  • Heart Murmur

Parents From Maine Are Reaching Out To For Litigation Details

The law firms of Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman, and Banville Law are the proprietors of The website serves a purpose of supplying relevant news about the Zofran lawsuit. Our attorneys are not authorized to practice law in the state of Maine, but we hold offices in Delaware where we are authorized to practice. Delaware is the state where GSK is headquartered which means we can pursue a Zofran litigation on behalf of your family when filed in Delaware. Find out more about our Delaware advocates and offices here.

To date many phone calls and contact forms have come our way from families residing in Maine with strong suspicions that Zofran taken for HG or NVM caused their child’s birth abnormality. We recognize that situations vary greatly and depending on yours we may find it suitable to file a Zofran case in Delaware or another suitable location, or we may refer you to local Maine legal counsel to pursue your case.

Our attorneys are here to speak with you at any time and we can guide you through this process. Please call us.

Look Here For Cleft Palate And CHD Information In Maine

Below you will find a list of websites that are specific to Maine in order to help and guide you with cleft palate and congenital heart defects information.

Call Now Button